327 related articles for article (PubMed ID: 23526068)
1. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.
de Jonge C; Rensen SS; Verdam FJ; Vincent RP; Bloom SR; Buurman WA; le Roux CW; Schaper NC; Bouvy ND; Greve JW
Obes Surg; 2013 Sep; 23(9):1354-60. PubMed ID: 23526068
[TBL] [Abstract][Full Text] [Related]
2. Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders.
Stratmann B; Krepak Y; Schiffer E; Jarick I; Hauber M; Lee-Barkey YH; Fischer M; Tschoepe D
Horm Metab Res; 2016 Sep; 48(10):630-637. PubMed ID: 27589345
[TBL] [Abstract][Full Text] [Related]
3. Role of proximal gut exclusion from food on glucose homeostasis in patients with Type 2 diabetes.
Cohen R; le Roux CW; Papamargaritis D; Salles JE; Petry T; Correa JL; Pournaras DJ; Galvao Neto M; Martins B; Sakai P; Schiavon CA; Sorli C
Diabet Med; 2013 Dec; 30(12):1482-6. PubMed ID: 23802863
[TBL] [Abstract][Full Text] [Related]
4. Endocrine effects of duodenal-jejunal exclusion in obese patients with type 2 diabetes mellitus.
Kaválková P; Mráz M; Trachta P; Kloučková J; Cinkajzlová A; Lacinová Z; Haluzíková D; Beneš M; Vlasáková Z; Burda V; Novák D; Petr T; Vítek L; Pelikánová T; Haluzík M
J Endocrinol; 2016 Oct; 231(1):11-22. PubMed ID: 27474690
[TBL] [Abstract][Full Text] [Related]
5. Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation.
Betzel B; Cooiman MI; Aarts EO; Janssen IMC; Wahab PJ; Groenen MJM; Drenth JPH; Berends FJ
Surg Endosc; 2020 Jan; 34(1):209-215. PubMed ID: 30877567
[TBL] [Abstract][Full Text] [Related]
6. Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes.
Jirapinyo P; Haas AV; Thompson CC
Diabetes Care; 2018 May; 41(5):1106-1115. PubMed ID: 29678867
[TBL] [Abstract][Full Text] [Related]
7. The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes.
Rohde U; Federspiel CA; Vilmann P; Langholz E; Friis SU; Krakauer M; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
Diabetes Obes Metab; 2017 Feb; 19(2):189-199. PubMed ID: 27696668
[TBL] [Abstract][Full Text] [Related]
8. Trends in BMI, Glycemic Control and Obesity-Associated Comorbidities After Explantation of the Duodenal-Jejunal Bypass Liner (DJBL).
Riedel N; Laubner K; Lautenbach A; Schön G; Schlensak M; Stengel R; Eberl T; Dederichs F; Aberle J; Seufert J
Obes Surg; 2018 Aug; 28(8):2187-2196. PubMed ID: 29504053
[TBL] [Abstract][Full Text] [Related]
9. Changes in glycemic control and body weight after explantation of the duodenal-jejunal bypass liner.
Betzel B; Koehestanie P; Homan J; Aarts EO; Janssen IM; de Boer H; Wahab PJ; Groenen MJ; Berends FJ
Gastrointest Endosc; 2017 Feb; 85(2):409-415. PubMed ID: 27451295
[TBL] [Abstract][Full Text] [Related]
10. Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.
Højberg PV; Vilsbøll T; Zander M; Knop FK; Krarup T; Vølund A; Holst JJ; Madsbad S
Diabet Med; 2008 Nov; 25(11):1268-75. PubMed ID: 19046215
[TBL] [Abstract][Full Text] [Related]
11. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
Rohde U
Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
[TBL] [Abstract][Full Text] [Related]
12. Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes.
Rodriguez L; Reyes E; Fagalde P; Oltra MS; Saba J; Aylwin CG; Prieto C; Ramos A; Galvao M; Gersin KS; Sorli C
Diabetes Technol Ther; 2009 Nov; 11(11):725-32. PubMed ID: 19905889
[TBL] [Abstract][Full Text] [Related]
13. Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner.
de Moura EG; Martins BC; Lopes GS; Orso IR; de Oliveira SL; Galvão Neto MP; Santo MA; Sakai P; Ramos AC; Garrido Júnior AB; Mancini MC; Halpern A; Cecconello I
Diabetes Technol Ther; 2012 Feb; 14(2):183-9. PubMed ID: 21932999
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of proximal small bowel exclusion by duodenal-jejunal bypass liner on weight reduction and glycemic control in diabetic patients.
Deutsch L; Ben Haim L; Sofer Y; Gluck N; Santo E; Fishman S
Surg Obes Relat Dis; 2018 Oct; 14(10):1561-1569. PubMed ID: 30449512
[TBL] [Abstract][Full Text] [Related]
15. Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients.
Muñoz R; Dominguez A; Muñoz F; Muñoz C; Slako M; Turiel D; Pimentel F; Sharp A; Escalona A
Surg Endosc; 2014 Apr; 28(4):1056-62. PubMed ID: 24196558
[TBL] [Abstract][Full Text] [Related]
16. Metabolic surgery and intestinal gene expression: Digestive tract and diabetes evolution considerations.
Rodrigues MR; Santo MA; Favero GM; Vieira EC; Artoni RF; Nogaroto V; de Moura EG; Lisboa P; Milleo FQ
World J Gastroenterol; 2015 Jun; 21(22):6990-8. PubMed ID: 26078577
[TBL] [Abstract][Full Text] [Related]
17. Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study.
Betzel B; Homan J; Aarts EO; Janssen IMC; de Boer H; Wahab PJ; Groenen MJM; Berends FJ
Surg Endosc; 2017 Jul; 31(7):2881-2891. PubMed ID: 27804045
[TBL] [Abstract][Full Text] [Related]
18. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial.
Koehestanie P; de Jonge C; Berends FJ; Janssen IM; Bouvy ND; Greve JW
Ann Surg; 2014 Dec; 260(6):984-92. PubMed ID: 25072436
[TBL] [Abstract][Full Text] [Related]
19. Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
Nguyen KT; Billington CJ; Vella A; Wang Q; Ahmed L; Bantle JP; Bessler M; Connett JE; Inabnet WB; Thomas A; Ikramuddin S; Korner J
Diabetes; 2015 Sep; 64(9):3104-10. PubMed ID: 25901097
[TBL] [Abstract][Full Text] [Related]
20. Safety experience with the duodenal-jejunal bypass liner: an endoscopic treatment for diabetes and obesity.
Betzel B; Koehestanie P; Aarts EO; Dogan K; Homan J; Janssen IM; Wahab PJ; Groenen MJ; Berends FJ
Gastrointest Endosc; 2015 Nov; 82(5):845-52. PubMed ID: 25952090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
